mittal, V., yadav, R., RAjesh, T. (2025). CLINICAL PROFILE AND MANAGEMENT OF PATIENTS WITH CARCINOMA GALL BLADDER. , 31(1), 19-33. doi: 10.33762/basjsurg.2025.157118.1104
vinamra mittal; rajat yadav; T. K. RAjesh. "CLINICAL PROFILE AND MANAGEMENT OF PATIENTS WITH CARCINOMA GALL BLADDER". , 31, 1, 2025, 19-33. doi: 10.33762/basjsurg.2025.157118.1104
mittal, V., yadav, R., RAjesh, T. (2025). 'CLINICAL PROFILE AND MANAGEMENT OF PATIENTS WITH CARCINOMA GALL BLADDER', , 31(1), pp. 19-33. doi: 10.33762/basjsurg.2025.157118.1104
mittal, V., yadav, R., RAjesh, T. CLINICAL PROFILE AND MANAGEMENT OF PATIENTS WITH CARCINOMA GALL BLADDER. , 2025; 31(1): 19-33. doi: 10.33762/basjsurg.2025.157118.1104

CLINICAL PROFILE AND MANAGEMENT OF PATIENTS WITH CARCINOMA GALL BLADDER

Basrah Journal of Surgery
Article 4, Volume 31, Issue 1, 2025, Pages 19-33    PDF (1.63 M)
Document Type: Original Article
DOI: 10.33762/basjsurg.2025.157118.1104
Authors
vinamra mittal* 1; rajat yadav2; T. K. RAjesh3
1Clinical Attachment, Dept. Of Colorectal Surgery, Derriford Hospital, Plymouth, United Kingdom.
2SHO, Department of Colorectal Surgery, Derriford Hospital Plymouth, United Kingdom
3Senior Consultant, Department of Colorectal Surgery, Derriford Hospital, Plymouth University Hospitals, NHS Trust, Plymouth, United Kingdom
Abstract
Gallbladder cancer (GBC) is an aggressive malignancy with an extremely poor prognosis. It is the most common cancer of the biliary tree. The early symptoms of gallbladder carcinoma are generally nonspecific and often mimic those of more common calculous biliary diseases. As a result, most cases are diagnosed at an advanced stage, leading to a dismal prognosis, with a five-year survival rate of less than 5%.

Materials & Methods
This prospective observational study focuses on the epidemiology and clinical profile of patients diagnosed with gallbladder carcinoma who presented to the Department of Surgery at BPKIHS, Dharan, over a one-year period from September 2017 to September 2018. A total of 30 patients with either diagnosed or incidental gallbladder carcinoma were included in the study.

Results
Most patients (n=26, 86.6%) presented within six months of symptom onset. The median duration of illness was 2±5.89 months, ranging from 0.5 to 24 months. Transabdominal ultrasonography detected the disease in 26 (86.6%) of the 30 cases, with the most commonly affected sites being the fundus and body (76.9%).

Among 14 cases deemed resectable based on CT imaging, intraoperative findings revealed that seven (50%) were unresectable—three due to metastasis and four due to locally advanced disease with hilar infiltration. Ultimately, seven patients underwent radical resection with curative intent.

Conclusion
This study highlights that gallbladder carcinoma predominantly affects middle-aged individuals, with a higher prevalence among females. The majority of cases are diagnosed at an advanced, often unresectable stage, underscoring the poor prognosis associated with the disease.
Keywords
Ca Gall Bladder; Inoperable Cholecystectomy; Unresectability
Supplementary Files
References
 

  1. Castro FA, Koshiol J, Hsing AW, Devesa SS. Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site. Int J cancer [Internet]. 2013 Oct 1 [cited 2018 Oct 17];133(7):1664-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23504585
    https://doi.org/10.1002/ijc.28161
  2. Khan I, Panda N, Banerjee M, Das R. Epidemiological Factors in Gall Bladder Cancer in Eastern India-A Single Centre Study.
  3. Andia ME, Hsing AW, Andreotti G, Ferreccio C. Geographic variation of gallbladder cancer mortality and risk factors in Chile: A population‐based ecologic study. Int J Cancer [Internet]. 2008 Sep 15 [cited 2018 Sep 22];123(6):1411-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18566990
    https://doi.org/10.1002/ijc.23662
  4. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer. 2006;118(7):1591-602.
    https://doi.org/10.1002/ijc.21683
  5. Fong Y, Malhotra S. Gallbladder cancer: recent advances and current guidelines for surgical therapy. Adv Surg [Internet]. 2001 [cited 2018 Sep 21];35:1-20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11579805
  6. Shaffer E, Hundal R. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol [Internet]. 2014 Mar [cited 2018 Sep 22];6:99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24634588
    https://doi.org/10.2147/CLEP.S37357
  7. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018 Sep 12 [cited 2018 Oct 28]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/30207593
    https://doi.org/10.3322/caac.21492
  8. Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol [Internet]. 2008 Mar [cited 2018 Oct 17];34(3):306-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17964753
    https://doi.org/10.1016/j.ejso.2007.07.206
  9. Ghimire P, Yogi N, Shrestha BB. Incidence of incidental carcinoma gall bladder in cases of routine cholecystectomy. Kathmandu Univ Med J (KUMJ) [Internet]. [cited 2018 Sep 23];9(34):3-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2261085 https://doi.org/10.3126/kumj.v9i2.6278
  10. Jin K, Lan H, Zhu T, He K, Teng L. Gallbladder carcinoma incidentally encountered during laparoscopic cholecystectomy: how to deal with it. Clin Transl Oncol [Internet]. 2011;13(1):25-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21239352
    https://doi.org/10.1007/s12094-011-0613-1
  11. Shirai Y, Yoshida K, Tsukada K, Muto T. Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg [Internet]. 1992 Apr [cited 2018 Oct 30];215(4):326-31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1558412
    https://doi.org/10.1097/00000658-199204000-00004
  12. Benoist S, Panis Y, Fagniez PL. Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg [Internet]. 1998 Feb [cited 2018 Oct 30];175(2):118-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9515527
    https://doi.org/10.1016/S0002-9610(97)00269-9
  13. Agarwal AK, Mandal S, Singh S, Bhojwani R, Sakhuja P, Uppal R. Biliary Obstruction in Gall Bladder Cancer Is Not Sine Qua Non of Inoperability. Ann Surg Oncol [Internet]. 2007 Sep 19 [cited 2018 Oct 31];14(10):2831-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17632759
    https://doi.org/10.1245/s10434-007-9456-y
  14. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol [Internet]. 2004 Mar [cited 2018 Oct 19];11(3):310-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14993027
    https://doi.org/10.1245/ASO.2004.03.011
  15. Perpetuo MD, Valdivieso M, Heilbrun LK, Nelson RS, Connor T, Bodey GP. Natural history study of gallbladder cancer: a review of 36 years experience at M. D. Anderson Hospital and Tumor Institute. Cancer [Internet]. 1978 Jul [cited 2017 Mar 19];42(1):330-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/667804
    https://doi.org/10.1002/1097-0142(197807)42:1<330::AID-CNCR2820420150>3.0.CO;2-F
  16. Dasari BVM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Roberts KJ, et al. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol [Internet]. 2018 Sep [cited 2018 Oct 29];118(3):477-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30259519
    https://doi.org/10.1002/jso.25186
  17. George R, Godara S, Dhagat P, Som P. Computed Tomographic Findings in 50 Cases of Gall Bladder Carcinoma. Med J Armed Forces India [Internet]. 2007 Jul [cited 2017 Mar 18];63(3):215-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27408000
    https://doi.org/10.1016/S0377-1237(07)80137-7
  18. Lee SW, Kim HJ, Park JH, Park D Il, Cho YK, Sohn C Il, et al. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol [Internet]. 2010 May 25 [cited 2018 Oct 31];45(5):560-6. Available from: http://link.springer.com/10.1007/s00535-009-0188-6
    https://doi.org/10.1007/s00535-009-0188-6
  19. Kumaran V, Gulati M, Paul S, Pande G, Sahni P, Chattopadhyay T. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol [Internet]. 2002 Aug 19 [cited 2018 Oct 18];12(8):1993-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12136317
    https://doi.org/10.1007/s00330-002-1440-0
  20. Aldossary MY, Alayed AA, Amr SS, Alqahtani S, Alnahawi M, Alqahtani MS. Gallbladder cancer in Eastern Province of Saudi Arabia: A retrospective cohort study. Ann Med Surg [Internet]. 2018 Nov [cited 2018 Oct 29];35:117-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30294442
    https://doi.org/10.1016/j.amsu.2018.09.020
  21. Birnbaum DJ, Viganò L, Ferrero A, Langella S, Russolillo N, Capussotti L. Locally advanced gallbladder cancer: Which patients benefit from resection? Eur J Surg Oncol [Internet]. 2014 Aug [cited 2018 Nov 1];40(8):1008-15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24246608
    https://doi.org/10.1016/j.ejso.2013.10.014
  22. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer [Internet]. 1995 Jan 1 [cited 2018 Oct 19];75(1 Suppl):171-90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8000995
    https://doi.org/10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2
  23. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg [Internet]. 2000;232(4):557-69. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1421188&tool=pmcentrez&rendertype=abstract
    https://doi.org/10.1097/00000658-200010000-00011
  24. Negi SS, Singh A, Chaudhary A. Lymph Nodal Involvement as Prognostic Factor in Gallbladder Cancer: Location, Count or Ratio? J Gastrointest Surg [Internet]. 2011 Jun 13 [cited 2018 Oct 29];15(6):1017-25. Available from: http://link.springer.com/10.1007/s11605-011-1528-4
    https://doi.org/10.1007/s11605-011-1528-4
  25. Tsukada K, Kurosaki I, Uchida K, Shirai Y, Oohashi Y, Yokoyama N, et al. Lymph node spread from carcinoma of the gallbladder. Cancer [Internet]. 1997 Aug 15 [cited 2017 Mar 20];80(4):661-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9264348
    https://doi.org/10.1002/(SICI)1097-0142(19970815)80:4<661::AID-CNCR3>3.0.CO;2-Q
 

  1. Ogura Y, Mizumoto R, Isaji S, Kusuda T, Matsuda S, Tabata M. Radical operations for carcinoma of the gallbladder: Present status in Japan. World J Surg [Internet]. 1991 May [cited 2018 Oct 30];15(3):337-43. Availablefrom: http://link.springer.com/10.1007/BF01658725
    https://doi.org/10.1007/BF01658725
  2. Tsukada K, Hatakeyama K, Kurosaki I, Uchida K, Shirai Y, Muto T, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery [Internet]. 1996 Nov [cited 2018 Nov 1];120(5):816-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8909516
    https://doi.org/10.1016/S0039-6060(96)80089-4
 

  1. Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery [Internet]. 1989 Sep [cited 2018 Nov 1];106(3):467-73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2772822
  2. Yamaguchi K, Enjoji M. Carcinoma of the gallbladder. A clinicopathology of 103 patients and a newly proposed staging. Cancer [Internet]. 1988 Oct 1 [cited 2018 Nov 1];62(7):1425-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3166397
    https://doi.org/10.1002/1097-0142(19881001)62:7<1425::AID-CNCR2820620730>3.0.CO;2-T
  3. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol [Internet]. 2010 Jun 24 [cited 2018 Nov 1];17(6):1471-4. Available from: http://www.springerlink.com/index/10.1245/s10434-010-0985-4
    https://doi.org/10.1245/s10434-010-0985-4
 

  1. Edeline J, Bonnetain F, Phelip JM, Watelet J, Hammel P, Joly J-P, et al. Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial. J Clin Oncol [Internet]. 2017 Feb [cited 2018 Nov 2];35(4_suppl):225-225. Available from: http://ascopubs.org/doi/10.1200/JCO.2017.35.4_suppl.225
    https://doi.org/10.1200/JCO.2017.35.4_suppl.225
  2. Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) [Internet]. 2016 [cited 2018 Nov 2];18(11):872-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27527802
    https://doi.org/10.1016/j.hpb.2016.05.016
  3. Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, et al. National Trends in the Management and Survival of Surgically Managed Gallbladder Adenocarcinoma Over 15 years: A Population-Based Analysis. J Gastrointest Surg [Internet]. 2010 Oct 8 [cited 2018 Nov 2];14(10):1578-91. Available from: http://link.springer.com/10.1007/s11605-010-1335-3
    https://doi.org/10.1007/s11605-010-1335-3
Statistics
Article View: 708
PDF Download: 182


Journal Management System. Powered by iJournalPro.com